Table 2.
Immune cell infiltrates in the prostate of CP1-infected mice with and without cromolyn sodium salt + cetirizine di-hydrochloride combination treatment
| Cell Types | Treatments |
Unpaired t Test | |
|---|---|---|---|
| CP1 Untreated | CP1 + Treatment | ||
| CD45+ lymphocytes | 23,024 ± 10,122 | 20,780 ± 11,296 | 0.6223ns |
| CD3+ T cells | 3,197 ± 3,201 | 1,666 ± 466.8 | 0.3805ns |
| CD4+ T cells | 505 ± 45.26 | 343.8 ± 82.27 | 0.0139* |
| CD8+ T cells | 1,122 ± 235.2 | 655.5 ± 169.7 | 0.0182* |
| B220+ B cells | 329 ± 351.3 | 181 ± 87.64 | 0.4449ns |
| CD11b+ monocytes/macrophages | 2,800 ± 1,138 | 1,315 ± 300.6 | 0.0451* |
| CD11c+ dendritic cells | 3,171 ± 1,808 | 1,218 ± 148 | 0.0747† |
Values are presented as means ± SD; n = 4 mice/group. Numbers of infiltrating cells in the prostate of CP1-infected C57BL/6 mice with or without cromolyn sodium salt + cetirizine di-hydrochloride treatment at “early treatment” (day 14 postinfection) are shown. Unpaired t test values are also indicated. *P < 0.05; †P < 0.1. ns, not significant.